1. 106518636 4‑氯‑2‑（三氟乙酰基）苯胺盐酸盐水合物及其游离碱的制备方法
CN
22.03.2017
C07C 45/46 Loading...
C07C 45/46
Loading...
102016000907003
浙江天宇药业股份有限公司
屠勇军
C07C 45/46
Loading...
本发明公开了一种4‑氯‑2‑(三氟乙酰基)苯胺盐酸盐水合物及其游离碱的制备方法，所述方法包括步骤：(1)使结构如式Ⅳ所示化合物经反应得到的中间体与三氟乙酸酯或结构如式Ⅴ或结构如式Ⅵ所示的化合物反应后，经酸处理得到结构如式Ⅰ所示的化合物；(2)使结构如式Ⅰ所示的化合物在酸的催化下发生硝化反应，得到结构如式Ⅱ所示的化合物；和(3)使结构如式Ⅱ所示的化合物经还原硝基成氨基而得到结构如式Ⅲ所示的化合物。
2. 105820064 一种联苯基丙氨醇衍生物的合成方法及中间体
CN
03.08.2016
C07C 269/06 Loading...
C07C 269/06
Loading...
201610236453.3
浙江天宇药业股份有限公司
朱国荣
C07C 269/06
Loading...
本发明公开了一种联苯基丙氨醇衍生物的合成方法及中间体。该合成方法包括下述步骤：有机溶剂中，在含氟离子的盐的作用下，化合物4发生脱硅保护反应，即可；其中，R1为氨基保护基，R2为叔丁基二甲基硅基、三甲基硅基、三乙基硅基、三异丙基硅基或叔丁基二苯基硅基。本发明使用的原辅料廉价易得，有利于降低工业化生产的成本，且合成路线简捷高效，各个步骤反应条件温和，环境友好，易于工业化生产。
3. 105348209 一种抗心衰药LCZ696的制备方法
CN
24.02.2016
C07D 257/04 Loading...
C07D 257/04
Loading...
201510903519.5
浙江天宇药业股份有限公司
王臻
C07D 257/04
Loading...
本发明公开了一种抗心衰药LCZ696的制备方法。该制备方法包括下述步骤：有机溶剂中，在氢氧化钠水溶液的作用下，沙库比曲二环己胺盐与缬沙坦反应，即可。本发明的制备方法工艺简单，省去现有的生产工艺中的钠盐到钙盐的离子交换和盐酸游离的工序，且不存在钙离子残留，有效提高生产效率。
4. 103360380 一种利伐沙班的合成方法和利伐沙班的中间体及其制备
CN
20.01.2016
C07D 413/10 Loading...
C07D 413/10
Loading...
201310080291.5
浙江天宇药业股份有限公司
徐少军
C07D 413/10
Loading...
本发明涉及一种新的利伐沙班合成中间体(S)-4-(4-(2-氧代-5-（（三苯甲基氨基）甲基）恶唑烷-3-基)苯基)吗啉-3-酮，以及采用了该中间体的利伐沙班合成方法。与现有技术相比，本发明的利伐沙班合成方法更适合大规模工业生产。
5. 104262338 Synthetic method of apixaban and intermediate thereof
CN
07.01.2015
C07D 471/04 Loading...
C07D 471/04
Loading...
201410508729.X
浙江天宇药业股份有限公司
王臻
C07D 471/04
Loading...
The invention provides a synthetic method of apixaban described in the specification, wherein the apixaban is obtained by performing hydrolysis reaction on a compound 8 and hydrogen peroxide in the presence of alkaline. The invention further discloses a preparation method of the compound, wherein the preparation method is described in the following scheme. The invention further provides an intermediate as shown in structural formulas 11, 12 and 13 of the apixaban. The synthetic method disclosed by the invention can be used for effectively avoiding side reactions such as ester exchange and hydrolysis in a process of synthesizing the apixaban, is beneficial to control over the apixaban quality; the reaction conditions are relatively simple and convenient, mild and environmentally friendly, the requirements on equipment are not high, the dosage of the auxiliary reagent is relatively small, the use of an ammonia source is avoided, the reaction yield of each step is relatively high, the auxiliary materials are less, the total cost is low, and thus, the synthetic method is suitable for industrial production.
6. 103319461 奥美沙坦酯中间体的制备方法以及奥美沙坦酯的合成方法
CN
25.09.2013
C07D 403/10 Loading...
C07D 403/10
Loading...
201310278106.3
临海天宇药业有限公司
张毅
C07D 403/10
Loading...
本发明涉及奥美沙坦酯的中间体4-(1-羟基-1-甲基乙基)-2-丙基-1-[[2’-[2-(1-甲基-1-苯基乙基)四唑-5-基]联苯-4-基]甲基]咪唑-5-羧酸的制备方法，以及另一种奥美沙坦酯中间体4-(1-羟基-1-甲基乙基)-2-丙基-1-[[2’-[2-(1-甲基-1-苯基乙基)四唑-5-基]联苯-4-基]甲基]咪唑-5-羧酸(5-甲基-2-氧代-1,3-二氧杂环戊烯-4-基)甲基酯的制备方法，以及奥美沙坦酯的合成方法。与现有技术相比，本发明的方法更简便更经济。
7. 102491928 一种制备(2S)-N-氯乙酰基-2-氰基四氢吡咯的方法
CN
13.06.2012
C07D 207/16 Loading...
C07D 207/16
Loading...
201110413447.8
临海天宇药业有限公司
黄正良
C07D 207/16
Loading...
本发明一种制备(2S)-N-氯乙酰基-2-氰基四氢吡咯的方法，属于化学药物中间体制备方法技术领域。所述制备方法包括：(1)L-脯氨酸与氯化亚砜发生酰化反应，得到L-脯氨酰氯；(2)L-脯氨酰氯与氨水发生反应生成L-脯氨酰胺；(3)L-脯氨酰胺与氯乙酰氯发生反应得到(2S)-N-氯乙酰基-2-甲酰胺基吡咯；(4)(2S)-N-氯乙酰基-2-甲酰胺基四氢吡咯在低温条件下与三氯氧磷发生脱水反应生成(2S)-N-氯乙酰基-2-氰基四氢吡咯。本发明具有节省原料成本；工艺流程相对简单，反应条件温和，操作难度不大，更具可操作性；后处理方便；制备的产物收率大幅度提高，质量稳定宜于大规模工业生产的优点。
8. 102432558 一种合成厄贝沙坦及其中间体的方法
CN
02.05.2012
C07D 257/04 Loading...
C07D 257/04
Loading...
201110353841.7
浙江天宇药业股份有限公司
屠勇军
C07D 257/04
Loading...
本发明一种合成厄贝沙坦及其中间体的方法，属于药物制备方法技术领域，具体涉及。通过一个便利的新的反应过程用α-甲基苯乙烯在有机酸催化下来保护5-(4’-甲基联苯-2-基)-2-(1-甲基-1-苯基乙基)四唑，溴代苄基，相转移下固液相缩合得到1-甲基-1-苯基乙基保护的厄贝沙坦，酸水解保护得到厄贝沙坦和2-苯基-2-丙醇，2-苯基-2-丙醇经回收得到α-甲基苯乙烯。本发明具有合成工艺适于工业生产并能产生经济价值，合成过程安全，节约原料成本，后续产物易处理以及反应原料单一，合成方法便利的优点。
9. WO/2011/082506 METHOD FOR PREPARING ALISKIREN AND INTERMEDIATE THEREOF
WO
14.07.2011
C07D 307/33 Loading...
C07D 307/33
Loading...
PCT/CN2010/000526
ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.
TU, Yongjun
C07D 307/33
Loading...
A method for preparing Aliskiren and intermediate thereof, which comprises the following steps: reacting 4-bromo-1-methoxy-2-(3-methoxypropoxy)benzene with magnesium isopropyl chloride and n-BuLi to obtain the compound of formula XXII; reacting the product of methylsulfonylation of the compound of formula XIX with anhydrous LiBr to obtain the compound of formula XXI; obtaining the intermediate of Aliskiren shown as formula XV by reacting the compound of formula XXII with the compound of formula XXI in an ether as the solvent and in the presence of a catalyst containing iron; then reacting the compound of formula XV with the compound of formula VII to obtain the compound of formula XXIII, following removing R1 from the amino group and obtaining Aliskiren shown as formula I.
10. 102079725 Method for preparing 2-chloropyrimidine
CN
01.06.2011
C07D 239/30 Loading...
C07D 239/30
Loading...
201110029469.4
Taizhou Erkang Pharmaceutical Co., Ltd.
Huang Zhengliang
C07D 239/30
Loading...
The invention discloses a method for preparing 2-chloropyrimidine, belonging to the technical field of methods for preparing chemical medicine intermediates. The method for preparing the 2-chloropyrimidine comprises the following steps of: (1) reacting dicyandiamide with ammonium chloride at high temperature, and obtaining guanidine hydrochloride; (2) reacting the guanidine hydrochloride with 1.1.3.3-tetramethoxypropane by refluxing under the condition of taking industrial hydrochloric acid as a solvent to obtain 2-amino pyrimidine; and (3) reacting the 2-amino pyrimidine with sodium nitrate at low temperature for producing the 2-chloropyrimidine by taking zinc chloride as a catalyst and taking the industrial hydrochloric acid as the solvent. The preparation method disclosed by the invention has the advantages of lower cost of raw materials, relatively simple technical process, mild reaction conditions, low operation difficulty, excellent maneuverability; convenience for post-treatment; and largely improved yield stable quality and applicability of large-scale industrial production of prepared products,.
11. 101817724 Preparation method of 1,2,4-trifluoro-benzene
CN
01.09.2010
C07C 25/13 Loading...
C07C 25/13
Loading...
201010176238.1
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Huang Zhengliang
C07C 25/13
Loading...
The invention relates to a preparation method of 1,2,4-trifluoro-benzene, belonging to the technical field of preparation methods of chemical drug intermediates. The preparation method comprises the following steps of: (1) generating salifying reaction on 3,4-difluoroaniline and fluoboric acid, and then generating diazotization reaction with sodium nitrite to obtain fluoboric acid diazonium salt; and (2) under the solvent-free condition, carrying out high-temperature cracking reaction on the fluoboric acid diazonium salt at the temperature of 80-300 DEG C to obtain 1,2,4-trifluoro-benzene. The preparation method has the advantages of cost saving of raw materials, relatively simple process flow, mild reaction condition, low operation difficulty, operability and convenient aftertreatment; and the prepared products have the purity increased to 98 percent or more now from 80 percent or less originally, are stable in quality, and are suitable for large-scale industrial production.
12. 101774986 Method for preparing aliskiren and intermediate thereof
CN
14.07.2010
C07D 307/33 Loading...
C07D 307/33
Loading...
201010000057.3
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Cheng Rongde
C07D 307/33
Loading...
The invention relates to a method for preparing aliskiren and an intermediate thereof, which belongs to the technical field of the drug preparation method. The method comprises the following steps: obtaining a compound as shown in Formula XXII and a compound as shown in Formula XIX through reaction of 4-bromine-1-methoxy-2-(3-methoxy-propoxy) benzene with isopropyl magnesium chloride and butyllithium, preparing a compound as shown in Formula XXI though reaction with anhydrous lithium bromide after acidylation with methanesulfonic acid, and preparing an aliskiren intermediate in the ether solvent in the action of a Fe-containing catalyst; and preparing the aliskiren as shown in Formula I through removing R1 on amino of a compound as shown in Formula XXIII obtained through reaction of the compound as shown in Formula XV and a compound as shown in Formula VII. The invention has the advantages of low cost of raw materials, simple synthetic method and easy industrialization and the like.
13. 101172968 2-propyl-4 methyl-6-(tolimidazole-2group) benzoglioxaline salt and method for producing the same
CN
07.05.2008
C07D 235/06 Loading...
C07D 235/06
Loading...
200610117824.2
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Tu Yongjun
C07D 235/06
Loading...
The invention relates to an intermediate 2-n-propyl-4 methyl-6-(methyl benzimidazole-2- radical) benzimidazole salt for high blood pressure resistance medicine that is telmisartan and the preparation method thereof. The intermediate has no any reports in the literature. The invention has the advantages of easy control of the preparation reaction condition, easy getting of raw material, and being suitable for mass production. The intermediate can be used for preparing the telmisartan.
14. 101045712 Synthesis method of valsartan
CN
03.10.2007
C07D 257/04 Loading...
C07D 257/04
Loading...
200710090688.7
Tu Yongjun
Tu Yongjun
C07D 257/04
Loading...
This invention relates to a new synthetic method of valsartan, includes preparation method of intermediate N - ( 1 - oxygen amyl) - N - [ [ 2' - trityl - tetrazolium - 5 - group) - ( 1, 1' - dibenzyl) - 4 - group] - methyl] - L - valine. 2' - ( N - trityl) tetrazolium - 4 - bromoethyl Biphenyl and valine methyl ester ( or other salt) carry out alkylation reaction, after acidylation, by alkaline hydrolysis and acidification to obtain intermediate N - ( 1 - oxygen amyl) - N - [ [ 2' - trityl - tetrazolium - 5 - group) - ( 1, 1' - dibenzyl) - 4 - group] - methyl] - L - valine, then by protection solution to gain Valsartan. This invention belong to pharmaceutical chemistry and organic chemistry region, possess merits of raw material stabilization, yield higher, valsartan optical purity high, industrialization operating easy and so on.
15. 1931838 Azacyclo butanone derivative and its synthesis process
CN
21.03.2007
C07D 205/08 Loading...
C07D 205/08
Loading...
200610150638.9
Tu Yongjun
Tu Yongjun
C07D 205/08
Loading...
The present invention is one kind of compound as shown in the general expression VI and its application in prepared the azacyclo butanone compound through reaction in organic inert solvent at the temperature from -55 deg.c to 100 deg.c. The azacyclo butanone compound may have its ketocarbonyl radical reduced into hydroxyl radical in different processes to prepare ezetimibe and its analogs.
16. 1844110 Method for synthesizing Valsartan with high optical purity
CN
11.10.2006
C07D 257/04 Loading...
C07D 257/04
Loading...
200510130401.X
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Tu Yongjun
C07D 257/04
Loading...
The invention relates to a synthesis of high optical purify N-[[2'-(1H- tetrazoline-5-group)- (1,1'- diphenyl)-4-group]-methyl-]-L-valine, and using it as raw material in the synthesis of high optical valsartan. Using the 2'- tetrazoline group-4-methyl bromide biphenyl protected by tetrazoline and esterification protected carboxyl of L- valine(its salt) as raw material, by nucleophilic substitution, doing deprotective reaction in acidic condition, getting high optical purify N-[[2'-(1H-tetrazoline-5-group)-(1,1'-diphenyl)-4-group]-methyl-]-L-valine; in the existence of lower aliphatic alcohol, condensing with n-valeryl chloride to synthesize the valsartan in temperature range -20deg C-40deg C, controlling pH value between 1.5-5.0.
17. 1800179 Method for preparing candestartan
CN
12.07.2006
C07D 403/10 Loading...
C07D 403/10
Loading...
200510131970.6
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Tu Yongjun
C07D 403/10
Loading...
The invention relates to a method for synthesizing ridge sha tan, which uses the 2-tert-butyl ketonic oxygen amido-3-nitro benzoate (I) and N-(trityl )-5-(4'-morphine methylbiphenyll-2-group) tetrazolium (II) as raw material to do N-alkanisation reaction, protecting-released reaction, reduction reaction, ring-closed reaction and ester hydrolytic reaction. <0The protecting-released reaction can slough trityl and tert-butyl ketonic oxygen protect group in the lower aliphatic alcohol organic mixing solution.

